Merck

RENFLEXIS - Cost

Updated as of: July 1st, 2024

HCPCS:

Q5104

HCPCS Code Descriptor:

Injection, infliximab-abda, biosimilar, (renflexis), 10 mg

Medicare Payment Limit:

The Renflexis Medicare Payment Limit is $29.911.

Average Sale Price:

RENFLEXIS ASP cost available once logged in. Renflexis is a biosimilar drug making the ASP calculation more complex. Renflexis's ASP is based on the average sale price of its biosimilar reference drug.

Medicare Co-Insurance Percentage:

The Renflexis Medicare Co-Insurance percentage is 20%. Renflexis's Medicare Co-Insurance amount is $5.982

APC Code:

The Renflexis: APC Code is: 9036

APC Payment Limit:

The APC Payment Limit for RENFLEXIS is available. Login to view.

Renflexis Cost Information:

Renflexis is assigned to the Q Code: Q5104 and is a biosimilar to the reference drug Remicade (J1745). Since the HCPCS effective date in April of 2018, the list price for Renflexis has remained the same. The ASP steadily declined from April 2018 until April 2022 where it rose significantly, and then began steadily declining again.

ACCESS PRICING AND MORE BY REGISTERING

Renflexis’s wholesale acquisition cost (WAC) information was last updated on:
August 28, 2019
Renflexis’s average wholesale price (AWP) information was last updated on:
August 28, 2019